SEC Form 4 · accession 0001179110-15-007705
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen A Dawes
Director
Period of report
May 12, 2015
Accepted (ET)
May 13, 2015 · 3:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $20.43 | May 12, 2015 | A | 7,857 | A | — | May 12, 2025 | Common Stock | 7,857 | 7,857 | D |
| Restricted Stock UnitF1,F3,F4 | — | May 12, 2015 | A | 2,936 | A | — | — | Common Stock | 2,936 | 2,936 | D |
Explanation of responses
- F1Automatic Grant of Stock Options and Restricted Stock Unit Awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy.
- F2Exercisable in twelve equal monthly installments.
- F3Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F4These restricted stock units are scheduled to vest on May 12, 2016, assuming continued service through the applicable vesting date.